
NASDAQTechnologySoftware - Application
Latest quote
$2.24
+$0.15 · +7.18%
Alpha Modus Holdings, Inc. develops, creates, and licenses advanced data-centric technologies. These innovations are designed to improve the digital experience for shoppers in physical retail locations, influencing their choices at the moment of purchase throughout the United States. The company also holds patents for a product line within its "571 patent family." Founded in 2014, its main operations are based in Cornelius, North Carolina.
Previous close
$2.24
+$0.15 · +7.18%
Regular session · ET · Market data may be delayed.
Alpha Modus Holdings, Inc. develops, creates, and licenses advanced data-centric technologies. These innovations are designed to improve the digital experience for shoppers in physical retail locations, influencing their choices at the moment of purchase throughout the United States. The company also holds patents for a product line within its "571 patent family." Founded in 2014, its main operations are based in Cornelius, North Carolina.
Day range
Current $2.24
52-week range
Current $2.24
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
37
Expensive
Sentiment
54
Mixed
Risk
68
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Alpha Modus Holdings, Inc. develops, creates, and licenses advanced data-centric technologies. These innovations are designed to improve the digital experience for shoppers in physical retail locations, influencing their choices at the moment of purchase throughout the United States. The company also holds patents for a product line within its "571 patent family." Founded in 2014, its main operations are based in Cornelius, North Carolina.
Day range
Current $2.24
52-week range
Current $2.24
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.